EDWARD GRAVISS to HLA Antigens
This is a "connection" page, showing publications EDWARD GRAVISS has written about HLA Antigens.
Connection Strength
0.427
-
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function. Clin Transplant. 2026 May; 40(5):e70576.
Score: 0.218
-
Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection. Transplantation. 2014 Mar 15; 97(5):534-40.
Score: 0.094
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clin Transplant. 2024 02; 38(2):e15249.
Score: 0.047
-
Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplant Proc. 2021 Jul-Aug; 53(6):1865-1871.
Score: 0.039
-
Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation. Clin Transplant. 2017 08; 31(8).
Score: 0.030